Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ONCONC
31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in BEONE MEDICINES LTD

Yes. Citadel Advisors holds 1,425,517 shares of ONC (BeOne Medicines), worth $406.2M, as of its Q2 2026 13F filing. It increased the position by 393,219 shares (+38.1%) from Q1 2026. Citadel Advisors has held ONC since Q4 2019, across 27 quarterly 13F filings.

Current Value

$406.2M

Current Shares

1.4M

Total Value Change

+$403.8M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+38.1%
$406.2M0.0%$284.97
41
2026-Q1
Increased
1M
+93.5%
$306.6M0.0%$296.97
49
2025-Q4
Increased
533,517
+1373.6%
$162.1M0.0%$303.81
49
2025-Q3
Decreased
36,205
-93.3%
$12.3M0.0%$340.70
0
2025-Q2
Decreased
537,156
-45.3%
$130M0.0%$242.07
0
2025-Q1
Increased
982,161
+209.7%
$267.3M0.1%$272.17
50
2024-Q4
Increased
317,113
+574.2%
$58.6M0.0%$184.71
47
2024-Q3
Increased
47,034
+713.7%
$10.6M0.0%$224.51
45
2024-Q2
Increased
5,780
+5738.4%
$824,6330.0%$142.67
40
2024-Q1
Decreased
99
-99.2%
$15,4830.0%$156.39
0
2023-Q4
Increased
11,821
+160.6%
$2.1M0.0%$180.36
42
2023-Q3
Decreased
4,537
-87.5%
$816,0700.0%$179.87
0
2023-Q2
Increased
36,391
+156.6%
$6.5M0.0%$178.30
44
2023-Q1
Decreased
14,184
-65.5%
$3.1M0.0%$215.53
0
2022-Q4
Increased
41,094
+53.2%
$9M0.0%$219.94
39
2022-Q3
Decreased
26,831
-35.9%
$3.6M0.0%$134.82
0
2022-Q2
Increased
41,875
+1165.9%
$6.8M0.0%$161.85
44
2022-Q1
Increased
3,308
+70.7%
$624,0000.0%$188.60
36
2021-Q4
Decreased
1,938
-94.0%
$525,0000.0%$270.93
0
2021-Q3
Increased
32,377
+359.6%
$11.8M0.0%$363.00
45
2021-Q2
Increased
7,045
+47.2%
$2.4M0.0%$343.19
36
2021-Q1
Decreased
4,785
-65.5%
$1.7M0.0%$348.08
0
2020-Q4
Decreased
13,888
-5.4%
$3.6M0.0%$258.39
0
2020-Q3
Increased
14,685
+717.2%
$4.2M0.0%$286.44
43
2020-Q2
Decreased
1,797
-84.0%
$339,0000.0%$188.40
0
2020-Q1
Decreased
11,195
-47.6%
$1.4M0.0%$123.11
0
2019-Q4
New
21,375
-
$3.5M0.0%$165.76
37
2019-Q3
Exited
0
-100.0%
$00.0%$122.46
0
2019-Q2
Increased
21,662
+59.2%
$2.7M0.0%$123.95
38
2019-Q1
Decreased
13,608
-19.9%
$1.8M0.0%$132.00
0
2018-Q4
First report
16,981
-
$2.4M0.0%$140.26
0

Other major holders of ONC: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used